This inventor holds 1 USPTO granted patent. Top assignee: Alta Diagnostic Machines Limited. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Ian Deverill: Innovator in Nephelometric Methods
Introduction
Ian Deverill is a notable inventor based in Mansfield, GB. He has made significant contributions to the field of diagnostic technology, particularly through his innovative patent related to the quantification of antigens and antibodies in blood samples. His work has implications for medical diagnostics and research.
Latest Patents
Ian Deverill holds a patent for a "Nephelometric method for determination of an antigen or antibody content." This method and apparatus are designed to quantify a component in a whole blood sample, where red cells are lysed. The process involves mixing the sample with a reagent to form an antigen-antibody complex. The sample is then exposed to a source of radiation, and the intensity of radiation scattered at a specific angle by the complex is measured. The apparatus includes a transparent container for the sample, which allows radiation within a wavelength of 460-530 nm to pass through. This innovative approach enhances the accuracy of diagnostic testing.
Career Highlights
Ian Deverill is associated with Alta Diagnostic Machines Limited, where he applies his expertise in developing advanced diagnostic solutions. His work at the company reflects his commitment to improving healthcare through innovative technologies.
Collaborations
Ian has collaborated with Arthur Randall Bradwell, contributing to the development of diagnostic methods and technologies. Their partnership has fostered advancements in the field, although specific details of their collaborations are not highlighted here.
Conclusion
Ian Deverill's contributions to the field of diagnostics through his innovative patent demonstrate his dedication to enhancing medical technology. His work continues to impact the way antigens and antibodies are quantified, paving the way for improved diagnostic practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile